Company intelligence / Profile preview

Viva Biotech

Shanghai, Shanghai, Chinavivabiotech.com ↗

Ownership: Private
Employees: ~2063
Development stage: Commercial

Overview

Viva Biotech provides comprehensive contract research and manufacturing services from early-stage structure-based drug discovery through commercial manufacturing. It has leading expertise in structural biology/biophysics and offers advanced platforms such as SBDD and AI-driven approaches. The company also invests in innovative biotech startups via its BioInnovator arm. Its own clinical results are not directly reported since it operates primarily as a CRO/CDMO rather than developing proprietary drugs.

Therapeutic areas: OncologyDermatologyMetabolic DisordersImmunology
Modalities: Small moleculeMonoclonal antibodyPeptidesProteinAntibody-drug conjugateGene therapyCell therapy
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Viva Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viva Biotech.

Explore the full profile